Biotyscience Inc
E-mail biotyscience@gmail.com
info@biotyscience.com
Tel 400-669-8850
Cat No | AMMD-001 |
Conjugate | |
Type | 单克隆抗体 |
Clone | MAP-1 |
Source | Mouse |
Tag | N/A |
Size | 1mg |
Application | CLIA, FIA |
Format | Liquid |
Concentration | Please refer to the vial lable for the specific concentration. |
Buffer | 50 MM Na-citrate, pH 6.0, 0.9 % NaCI, 0.095 % NaN3 as a preservative |
Species | Human |
Storage | Store at -20 degree. Avoid repeated freeze/thaw cycles. |
Synonyms | PINP;Human procollagen I N-terminal peptide;COL1A1;Alpha 1 type I collagen;Alpha-1 type I collagen;CO1A1_HUMAN;COL1A1;Collagen alpha-1(I) chain;Collagen type I alpha 1;Procollagen type I N terminal propeptide;Procollagen type I N-terminal propeptide. |
Purification | Protein A/G |
MolecularWeight | |
Description | |
Background | The amino terminal propeptide (PINP) of type I procollagen is the n-terminal product cleaved by type I procollagenase during bone formation and eventually enters the bloodstream. As a bone transformation marker, PINP can be used to assess fracture risk and monitor osteoporosis outcomes. At the same time, PINP can also be used for Paget bone disease, osteoblastic metastasis, breast cancer, prostate cancer and children and adolescents growth process monitoring. PINP detection is currently divided into two types: full segment PINP and total PINP. Both are consistent in many clinical applications, but the results of full-segment PINP are more accurate when testing patients with renal dysfunction. |